DP
Deba Prasad Saha
About Deba Prasad Saha
Data last updated:
Deba Prasad Saha is a Director at Phylax Pharmaceuticals Private Limited (since 2012) and Additional Director at Sushrusha Diagnostics Private Limited (since 2023). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1.43 Cr; the largest is Phylax Pharmaceuticals Private Limited at ₹1.41 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 May 2012 | 2012 | ₹1.41 Cr (FY 2025) | Active | |
| Additional Director | 19 Jun 2023 | 2020 | ₹2.2 Lakh (FY 2022) | Active |
Board colleagues of Deba Prasad Saha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satya Prasad Saha | 05224612 | Phylax Pharmaceuticals Private Limited , Sushrusha Diagnostics Private Limited | Whole-Time Director |
| Suvadra Urmila Saha | 08019377 | Phylax Pharmaceuticals Private Limited , Sushrusha Diagnostics Private Limited | Director |
| Urmi Saha | 05224651 | Phylax Pharmaceuticals Private Limited , Sushrusha Diagnostics Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deba Prasad Saha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deba Prasad Saha
Deba Prasad Saha currently holds 2 directorships: Phylax Pharmaceuticals Private Limited (Director, since 07 May 2012, revenue ₹1.41 Cr (FY 2025)); Sushrusha Diagnostics Private Limited (Additional Director, since 19 Jun 2023, revenue ₹2.2 Lakh (FY 2022)).
Deba Prasad Saha was first appointed on 07 May 2012 as Director at Phylax Pharmaceuticals Private Limited. The most recent appointment on record is 19 Jun 2023 at Sushrusha Diagnostics Private Limited.
The 2 current companies of Deba Prasad Saha that report revenue have a combined latest revenue of ₹1.43 Cr: Phylax Pharmaceuticals Private Limited ₹1.41 Cr (FY 2025); Sushrusha Diagnostics Private Limited ₹2.2 Lakh (FY 2022).
The current boards of Deba Prasad Saha's companies include Satya Prasad Saha (Phylax Pharmaceuticals Private Limited), Suvadra Urmila Saha (Phylax Pharmaceuticals Private Limited), Urmi Saha (Phylax Pharmaceuticals Private Limited).